Gerald R. Crabtree
46Patents
19h-index
22Co-inventors
81Inventor score
Filing activity: Sep 20, 1993 → Jul 11, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5869337A | Regulated transcription of targeted genes and other biological events | Chemistry; Metallurgy | 117 | Expired |
| US5834266A | Regulated apoptosis | Chemistry; Metallurgy | 117 | Expired |
| US5830462A | Regulated transcription of targeted genes and other biological events | Chemistry; Metallurgy | 101 | Expired |
| US5871753A | Regulated transcription of targeted genes and other biological events | Chemistry; Metallurgy | 93 | Expired |
| US6165787A | Regulated transcription of targeted genes and other biological events | Chemistry; Metallurgy | 73 | Expired |
| US6372712B1 | Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand | Emerging Cross-Sectional Technologies | 68 | Expired |
| US6011018A | Regulated transcription of targeted genes and other biological events | Chemistry; Metallurgy | 53 | Expired |
| US6043082A | Regulated transcription of targeted genes and other biological events | Chemistry; Metallurgy | 52 | Expired |
| US6046047A | Regulated transcription of targeted genes and other biological events | Chemistry; Metallurgy | 51 | Expired |
| US6054436A | Regulated apoptosis | Chemistry; Metallurgy | 38 | Expired |
| US5994313A | Regulated apoptosis | Chemistry; Metallurgy | 35 | Expired |
| US6875571B2 | NF-AT polypeptides and polynucleotides and screening methods for immunosuppressive agents | Physics | 31 | Expired |
| US6140120A | Regulated transcription of targeted genes and other biological events | Chemistry; Metallurgy | 29 | Expired |
| US6984635B1 | Dimerizing agents, their production and use | Human Necessities | 26 | Expired |
| US7390784B2 | Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6921531B2 | Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy | Emerging Cross-Sectional Technologies | 24 | Expired |
| US7220552B1 | Bifunctional molecules and their use in the disruption of protein-protein interactions | Physics | 23 | Expired |
| US5523227A | DNA encoding calcium-signal modulating cyclophilin ligand | Physics | 21 | Expired |
| US6887842B1 | Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug | Emerging Cross-Sectional Technologies | 20 | Expired |
| US9410943B2 | Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma | Chemistry; Metallurgy | 17 | Active |
| US6972193B1 | Regulated transcription of targeted genes and other biological events | Chemistry; Metallurgy | 16 | Expired |
| US5403712A | Transcription cofactor assay | Chemistry; Metallurgy | 14 | Expired |
| US6063625A | Regulated transcription of targeted genes and other biological events | Chemistry; Metallurgy | 13 | Expired |
| US10105420B2 | Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma | Chemistry; Metallurgy | 12 | Active |
| US5837840A | NF-AT polypeptides and polynucleotides | Physics | 10 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.